Beranda › Kanker (semua jenis) › Ohio › Cincinnati
Uji klinis Kanker (semua jenis) di Cincinnati, OH
27 studi untuk Kanker (semua jenis) mencari peserta di lokasi sekitar Cincinnati (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Menerima pesertaFase 2
- University of Cincinnati Medical Center. /ID# 278925, Cincinnati
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
Menerima pesertaFase 3
- Oncology Hematology Care Clinical Trials, LLC, Fairfield · 15 mi jauhnya
Registry Study for Radiation Therapy Outcomes
Menerima pesertaStudi observasional
- University of Cincinnati Medical Center, Cincinnati
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Menerima pesertaFase 3
- Saint Elizabeth Medical Center Edgewood, Edgewood · 8 mi jauhnya
A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer
Menerima peserta
- Cincinnati Children's Hospital Medical Center, Cincinnati
Pan Tumor Rollover Study
Menerima pesertaFase 2
- Oncology Hematology Care, Cincinnati
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Menerima pesertaFase 3
- Oncology Hematology Care - Fairfield /ID# 280641, Fairfield · 15 mi jauhnya
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Menerima pesertaFase 2
- University of Cincinnati Medical Center, Cincinnati
- West Chester Hospital, West Chester · 15 mi jauhnya
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Menerima pesertaFase 2/3
- Oncology Hematology Care, Inc., Cincinnati
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
Menerima pesertaFase 3
- Research Site, Edgewood · 8 mi jauhnya
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Menerima pesertaFase 3
- USO - Oncology Hematology Care, Cincinnati
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Menerima pesertaStudi observasional
- University of Cincinnati, Cincinnati
Project: Every Child for Younger Patients With Cancer
Menerima pesertaStudi observasional
- Cincinnati Children's Hospital Medical Center, Cincinnati
International Rare Brain Tumor Registry
Menerima pesertaStudi observasional
- Cincinnati Children's Hospital Medical Center, Cincinnati
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Menerima pesertaFase 3
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Bethesda North Hospital, Cincinnati
- TriHealth Cancer Institute-Westside, Cincinnati
- dan 1 lainnya
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Menerima pesertaFase 3
- University of Cincinnati Physicians Group, LLC, Cincinnati
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
Menerima pesertaFase 1/2
- Oncology Hematology Care - Blue Ash /ID# 272918, Cincinnati
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Menerima pesertaFase 1
- University Of Cincinnati Medical Center /ID# 251746, Cincinnati
Tempus Small Cell Lung Cancer Observational Study (Sculptor)
Menerima pesertaStudi observasional
- TriHealth Cancer Institute, Cincinnati
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
Menerima pesertaFase 1/2
- University of Cincinnati, Cincinnati
Lattice Radiotherapy for Dose-Escalated Palliation of Bulky Tumors
Menerima pesertaFase 2
- University of Cincinnati Medical Center, Cincinnati
GEMINI-NSCLC: NSCLC Biomarker Study
Menerima pesertaStudi observasional
- TriHealth Cancer Institute, Cincinnati
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Cincinnati
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
Menerima pesertaFase 1
- The Christ Hospital Cancer Center, Cincinnati
A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
Menerima pesertaStudi observasional
- University of Cincinnati Medical Center, Cincinnati
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
Menerima pesertaStudi observasional
- TriHealth Cancer Institute, Cincinnati
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Menerima peserta
- University of Cincinnati, Cincinnati
- West Chester Hospital (OH394), West Chester · 15 mi jauhnya
Uji klinis Kanker (semua jenis) di kota lain
- Houston, TX121 studi
- New York City, NY110 studi
- Boston, MA86 studi
- Los Angeles, CA73 studi
- Nashville, TN65 studi
- Philadelphia, PA59 studi
- Durham, NC58 studi
- Washington, DC58 studi
- Chicago, IL51 studi
- Seattle, WA49 studi
- Atlanta, GA49 studi
- Arlington, VA48 studi
Studi lain di Cincinnati
- Kanker Paru Non-Sel Kecil35 studi
- Kanker Payudara25 studi
- Gagal Jantung24 studi
- Kanker Kolorektal21 studi
- Leukemia Mieloid Akut20 studi
- Kanker Metastatik20 studi
- Kanker Ovarium19 studi
- Kanker Paru19 studi
- Obesitas19 studi
- Kanker Prostat18 studi
- Mieloma Multipel17 studi
- Melanoma17 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.